Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
306 studies found for:    TRA
Show Display Options
Rank Status Study
21 Active, not recruiting Decitabine and Tretinoin in Treating Patients With Myelodysplastic Syndromes
Condition: Myelodysplastic Syndromes
Interventions: Drug: decitabine;   Drug: tretinoin;   Genetic: DNA methylation analysis;   Genetic: cytogenetic analysis;   Genetic: microarray analysis;   Other: flow cytometry;   Other: immunohistochemistry staining method
22 Completed Single Dose of 9-cis-retinoic Acid in Hepatic Patients
Condition: Hepatic Insufficiency
Intervention: Drug: 9-cis-retinoic acid
23 Completed Combination Therapy in Amyotrophic Lateral Sclerosis (ALS)
Condition: Amyotrophic Lateral Sclerosis
Interventions: Drug: Pioglitazone and Tretinoin;   Drug: Tretinoin and Pioglitazone HCL;   Drug: Placebo
24 Completed
Has Results
Adherence to Study Medication Compared to Generic Topical Clindamycin Plus Generic Topical Tretinoin in Subjects With Mild to Moderate Acne Vulgaris
Condition: Acne Vulgaris
Interventions: Drug: clindamycin phosphate 1.2% and tretinoin 0.025%;   Drug: clindamycin 1% gel;   Drug: tretinoin 0.025% cream
25 Completed
Has Results
Dapsone Gel 5% and Tretinoin Gel 0.025% Versus Tretinoin Gel 0.025% Monotherapy for Facial Acne Vulgaris
Condition: Acne Vulgaris
Interventions: Drug: Dapsone; Tretinoin;   Drug: Tretinoin
26 Completed
Has Results
Phase II 5-Azacytidine Plus VPA Plus ATRA
Conditions: Myelodysplastic Syndrome;   Acute Myelogenous Leukemia
Interventions: Drug: 5-Azacytidine (5-aza);   Drug: Valproic Acid;   Drug: All-Trans Retinoic Acid (ATRA)
27 Suspended Efficiency And Safety Of Association Arbutin, Triamcinolone And Tretinoin In Treatment Of Melasma
Condition: Melasma
Interventions: Drug: arbutin, tretinoin, triamcinolone;   Drug: Triluma
28 Completed Bioequivalence Study of Spear Tretinoin Gel 0.05% to Brand Tretinoin Gel
Condition: Acne
Intervention: Drug: Tretinoin
29 Completed
Has Results
Safety and Efficacy Study of Clindamycin Phosphate 1.2% and Tretinoin 0.025% Gel to Treat Rosacea
Condition: Rosacea
Interventions: Drug: Clindamycin Phosphate 1.2% And Tretinoin 0.025% Gel;   Drug: Placebo gel
30 Completed
Has Results
A Study That Evaluates the Decrease in Irritation When Using Additional Acne Treatment Products
Condition: Acne Vulgaris
Interventions: Drug: Dapsone plus Tretinoin Gel;   Drug: Tretinoin Gel
31 Completed 13-Cis Retinoic Acid With or Without Vitamin E for Prevention of Lung Cancer
Conditions: Drug Toxicity;   Lung Cancer
Interventions: Drug: 13-cis retinoic acid;   Dietary Supplement: Tocopherol
32 Completed Split-face Tolerability Comparison Between Adapalene-BPO Gel Versus Tretinoin Gel
Condition: Acne Vulgaris
Interventions: Drug: Epiduo Gel;   Drug: Retin-A Micro Microsphere 0.1%
33 Completed A Study of All-Trans Retinoic Acid (ATRA) and Bryostatin in Patients With Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)
Conditions: Acute Myelogenous Leukemia;   Myelodysplastic Syndrome
Interventions: Drug: All-trans retinoic acid;   Drug: Bryostatin 1
34 Completed A Study to Determine the Safety and Efficacy of Atralin (Tretinoin 0.05%) Gel for the Treatment of Rosacea
Condition: Rosacea
Interventions: Drug: tretinoin gel 0.05%;   Drug: vehicle
35 Completed Tretinoin and Arsenic Trioxide With or Without Idarubicin in Treating Patients With Acute Promyelocytic Leukemia
Condition: Leukemia
Interventions: Drug: arsenic trioxide;   Drug: idarubicin;   Drug: tretinoin
36 Completed
Has Results
Bioequivalence Study of Generic Tretinoin 0.1% Microsphere Gel, 0.1% Retin-A Micro® and Placebo
Condition: Acne
Interventions: Drug: Tretinoin microsphere 0.1%;   Drug: Brand Retin-A Micro tretinoin microsphere gel 0.1%;   Drug: placebo microsphere gel
37 Completed Bioequivalence Study Comparing Clindamycin Phosphate (1.2%) and Tretinoin (0.025%) Topical Gel to Ziana and Placebo
Condition: MILD TO SEVERE ACNE VULGARIS
Interventions: Drug: CLIND PHOSPHATE (1.2%) AND TRETINOIN (0.025%) TOPICAL GEL;   Drug: ZIANA®;   Drug: Vehicle Control
38 Completed Clinical Evaluation of the Photoallergy Potential of Atralin Gel
Condition: Healthy
Intervention: Drug: Atralin (tretinoin) gel, 0.05%
39 Recruiting All-Trans Retinoic Acid (ATRA) Combining Dexamethasone Versus High-dose Dexamethasone for Initial Treatment of Primary Immune Thrombocytopenia (ITP)
Conditions: Purpura;   Idiopathic Thrombocytopenic Purpura
Interventions: Drug: All-Trans Retinoid Acid(ATRA);   Drug: Dexamethasone
40 Completed W0265-104: A Single-Center, Evaluator-Blinded, Randomized, Placebo-Controlled, Phase 1 Clinical Trial Evaluating the Photoallergic Potential of Topically Applied Clindamycin Phosphate 1.0% and Tretinoin 0.025% (CT Gel) in Healthy Volunteers
Condition: Acne Vulgaris
Interventions: Drug: clindamycin1%/tretinoin 0.025% gel;   Drug: vehicle gel

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years